The Kaplan–Meier curve and log rank test analyses revealed that the high expression of Notch3 mRNA had a lower progression-free survival (PFS) rate in all pathological types of ovarian cancer, especially in serous ovarian cancer (Figure 6D). This evidence concerns the gene NOTCH3 and ovarian serous adenocarcinoma.